Sponsor content
325 result(s) found, displaying 91 to 100
-
Prescription medicine decision summaryThe medicine Imjudo (tremelimumab), in combination with durvalumab, is approved to treat adult patients with unresectable hepatocellular carcinoma (uHCC).
-
Prescription medicine registrationActive ingredients: andexanet alfa.
-
-
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ENHERTU trastuzumab deruxtecan 100 mg powder for injection vial.
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Prescription medicine registrationActive ingredients: trastuzumab deruxtecan.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BREZTRI AEROSPHERE 160/7.2/5 budesonide 160 mcg/glycopyrronium 7.2 mcg/formoterol fumarate dihydrate 5 mcg per actuation inhalation pMDI.